48.1% Below Target

The consensus Wall Street price target for MORN is $227.67, representing 48.1% upside from the current price of $153.68. With 6 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

MORN has a consensus rating of "Hold" based on 6 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $227.67 implies 48.1% upside from current levels.

With a forward P/E of 12.9163x, MORN trades at a relatively low valuation. The consensus target of $227.67 implies 48.1% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $280 for MORN, while the most conservative target is $193. The consensus of $227.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $335 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

MORN is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month MORN stock forecast based on 6 Wall Street analysts shows a consensus price target of $227.67, with estimates ranging from $193 (bear case) to $280 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $254, with bear/bull scenarios of $160/$335.

Our quantitative valuation model calculates MORN's fair value at $254 (base case), with a bear case of $160 and bull case of $335. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

MORN trades at a forward P/E ratio of 12.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on MORN, with a "Hold" consensus rating and $227.67 price target (48.1% upside). 2 of 6 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

MORN analyst price targets range from $193 to $280, a 38% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $227.67 consensus represents the middle ground. Our model's $160-$335 range provides an independent fundamental perspective.